share_log

Individual Investors Own 42% of China Meheco Group Co., Ltd. (SHSE:600056) Shares but Private Companies Control 53% of the Company

Individual Investors Own 42% of China Meheco Group Co., Ltd. (SHSE:600056) Shares but Private Companies Control 53% of the Company

个人投资者拥有中国医药集团股份有限公司(SHSE:600056)42%的股份,但私营企业控制公司的53%。
Simply Wall St ·  06/20 19:58

Key Insights

主要见解

  • The considerable ownership by private companies in China Meheco Group indicates that they collectively have a greater say in management and business strategy
  • The top 3 shareholders own 53% of the company
  • Past performance of a company along with ownership data serve to give a strong idea about prospects for a business
  • 中国医药集团的私营公司的大量持股表明,他们在管理和业务策略方面拥有更大的发言权。
  • 前三大股东拥有该公司53%的股份。
  • 公司过去的业绩以及所有权数据,有助于形成对业务前景的强烈想法。

To get a sense of who is truly in control of China Meheco Group Co., Ltd. (SHSE:600056), it is important to understand the ownership structure of the business. We can see that private companies own the lion's share in the company with 53% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

要想了解谁真正控制中国医药集团股份有限公司(SHSE:600056),了解业务的所有权结构是非常重要的。 我们可以看到,私营公司拥有公司53%的所有权。也就是说,如果股票上涨,该集团将会从中受益最多(如果存在经济下行风险,该集团也将会从中损失最多)。 而另一方面,个人投资者则占公司的42%的所有权。

And individual investors on the other hand have a 42% ownership in the company.

让我们仔细看一下不同类型的股东可以告诉我们关于中国医药集团的什么问题。

Let's take a closer look to see what the different types of shareholders can tell us about China Meheco Group.

SHSE:600056所有权结构分配2024年6月20日。

ownership-breakdown
SHSE:600056 Ownership Breakdown June 20th 2024
机构所有权告诉我们关于中国医药集团的什么信息?

What Does The Institutional Ownership Tell Us About China Meheco Group?

中国医药集团已经有机构在股东名册上。他们拥有公司相当大的股份。这表明在专业投资者中获得了某些信誉。但我们不能仅凭这个事实而依赖机构,因为机构有时会做出错误的投资,就像每个人都会犯错一样。如果两个大型机构投资者同时试图抛售股票,股价大幅下跌也是很常见的。因此,值得检查一下中国医药集团的过去收益轨迹(下面)。当然,还要记住,还有其他因素要考虑。

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

机构投资者通常将自己的回报与常见的指数回报进行比较。因此,他们通常会考虑购买包括在相关基准指数中的较大公司。

China Meheco Group already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of China Meheco Group, (below). Of course, keep in mind that there are other factors to consider, too.

SHSE:600056收益和营业收入增长2024年6月20日。

earnings-and-revenue-growth
SHSE:600056 Earnings and Revenue Growth June 20th 2024
对于中国医药集团,对冲基金的股份不多。该公司的最大股东是中国通用技术(集团)控股有限公司,拥有33%的股份。为了方便起见,第二大股东持有约10%的流通股份,第三大股东持有9.4%的股份。

Hedge funds don't have many shares in China Meheco Group. The company's largest shareholder is China General Technology (Group) Holding Co.,Ltd., with ownership of 33%. For context, the second largest shareholder holds about 10% of the shares outstanding, followed by an ownership of 9.4% by the third-largest shareholder.

中国医药集团的内部所有权。

To make our study more interesting, we found that the top 3 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

总的来说,包括散户投资者在内,公众拥有公司的14%的股份,因此不能轻易忽视。尽管这种所有权的规模可能不足以在他们的利益方面影响政策决策,但他们仍然可以对公司政策产生集体影响。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

普通公众持有北方铜业的23%股份。虽然这个群体不能决定公司的命运,但它肯定会对公司运营方式产生真正的影响。

Insider Ownership Of China Meheco Group

看起来,私营公司拥有中国医药集团的53%股份,这值得进一步深入研究。如果相关方,如内部人员,在这些私营公司之一拥有股权,那么这应该在年度报告中披露。私营公司也可能对公司有战略利益。

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

内部人员的定义在不同国家可能略有不同,但董事会成员总是计入内部人员。管理层最终向董事会回答。然而,经理往往会成为执行董事会成员,尤其是如果他们是创始人或CEO。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常认为内部人士持股是一件好事。但是,在某些情况下,它会使其他股东更难以对董事会的决定进行问责。

We note our data does not show any board members holding shares, personally. Given we are not picking up on insider ownership, we may have missing data. Therefore, it would be interesting to assess the CEO compensation and tenure, here.

我们注意到我们的数据不显示任何董事会成员持有股份。考虑到我们没有掌握内部持股情况,我们可能有缺失的数据。因此,有趣的是评估首席执行官的薪酬和任期。

General Public Ownership

一般大众所有权

The general public-- including retail investors -- own 42% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

包括零售投资者在内的公众持有该公司42%的股权,因此不能轻易被忽视。虽然这种所有权很可能不足以在政策决策上产生影响,但他们仍然可以对公司政策产生集体影响。

Private Company Ownership

私有公司的所有权

It seems that Private Companies own 53%, of the China Meheco Group stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我觉得查看拥有公司的人很有趣。但为了真正获得洞察力,我们需要考虑其他信息。比如风险,每个公司都有他们自己的风险,并且我们已经发现了中国医药集团的3个预警信号(其中1个有点令人担忧!)需要注意。

Next Steps:

下一步:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Like risks, for instance. Every company has them, and we've spotted 3 warning signs for China Meheco Group (of which 1 is a bit concerning!) you should know about.

Of course this may not be the best stock to buy. Therefore, you may wish to see our free collection of interesting prospects boasting favorable financials.

当然,这也可能不是最好的股票交易。因此,您可能想看看我们免费的潜力股票收藏,这些股票具有有利的财务状况。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发